Skip to content

MiMedx Group MDXG Asset turnover

Asset turnover at other companies

IAR
Integra LifeSciencesIART
0.4×0.0×
Artivion logo
ArtivionAORT
0.5×+0.1×
Solventum logo
SolventumSOLV
0.6×0.0×
Vericel logo
VericelVCEL
0.6×0.0×
Enovis logo
EnovisENOV
0.5×+0.1×
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
1.2×+0.2×

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Calculated from MiMedx Group’s reported figures.

Based on trailing twelve months.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's asset turnover?
MiMedx Group (MDXG) reported asset turnover of 1.3× in Q1 2026.
How has MiMedx Group's asset turnover changed year-over-year?
MiMedx Group's asset turnover decreased by 6.1% year-over-year, from 1.4× to 1.3×.
What is the long-term trend for MiMedx Group's asset turnover?
Over 5 years (2020 to 2025), MiMedx Group's asset turnover has grown at a 0.5% compound annual growth rate (CAGR), from 1.3× to 1.4×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.